Contact This Organization

Prescriptive Innovations

Prescriptive Innovations was founded to disrupt a market full of misaligned incentives, unethical pricing, antiquated healthcare technology, and unfulfilled hype.
We bring our passion and innovation to deliver real value to your prescription benefit in meaningful and transparent ways.
We offer an industry high guaranteed return-on-investment (ROI), no implementation fee, and transparent savings.
Utilizing our proprietary analytics and clinical algorithms, we systematically identify savings in every area of pharmacy. Our expert pharmacists guide providers and members to the lowest cost drugs to maximize savings. We are an independent company and do not have any conflicts of interest in order to focus on you best interest.
Mission: Relentlessly bring value to medication use through data driven end-to-end solutions throughout the supply chain, prescribing patterns, and patient behavior.

Vision: Rewriting medication use
Type of Organization
Startup - Newly established businesses, investable
Size of Organization
Organization Mailing Address

10740 N Park Ave N
Seattle, WA 98133
United States

We provide a end-to-end solution that combines advanced analytics with high touch clinical outreach to save money in every area of the prescription drug benefit.
Category of Innovation
Health IT - Health IT refers to the “pipes” or “infrastructure” that technological systems are built upon and that digital health solutions may use to provide information or other necessities. Ex. Electronic medical records (EMRs)
Intended End User
Payer - Organizations responsible for issuing or administering payment for the care received by a population of people (e.g. insurance companies)
Purchaser - Organizations responsible for purchasing health benefits for a population of people (e.g. employers or government entities)
Impactful Innovation Stage (Click Here for Details)
Problem (i.e. barrier, issue, complication, etc.) being solved for the end user
Pharmacy Benefit Managers (PBMs) are notorious for having conflicts of interest, opaque business practices, and poor performance. The top 3 PBMs own 85% of the market share and each own their own pharmacy chain. This incentivizes them to INCREASE cost. This is seen by the poor performance in their drug management and prior authorization. On a recent analysis, over 1/3 of the PAs that were approved, should have been denied. In addition on the same analysis, over half of the pharmacy spend did not have a PA and were 'preferred drugs'. There is significant waste and poor performance that employers and health plans are paying the price for.
Idea/solution to the problem, if applicable
The retroSAVE program enhances your current drug management by providing a safety net and checks to your PBM along with finding savings in every area of pharmacy. We provide an end-to-end solution that utilizes our proprietary analytics and algorithms to find savings and do outreach to providers and members by our expert clinical pharmacists to ensure actual savings. We are so confident that we offer a guaranteed ROI with no implementation fee.
Level of adoption (i.e. list of customers/users, testimonials, etc.), if applicable
In discussion with several health plans for pilot programs
Funding Stage
Not Applicable
Has your company attested to any codes of conduct?